New drugs for pancreatic cancer

A new drug candidate permanently modifies a wily cancer-causing mutation, paving the way for making pancreatic cancer treatable, or perhaps even curable.

NEW: Pancreatitis and pancreatic cancer. Guest Edited by Rupjyoti Talukdar omeprazole in symptomatic treatment of moderate gastroesophageal reflux.

pancreatic and other cancers. Patrick Sung, DPhil, director drug development for new and less-toxic treatments for childhood cancers.

Due to bile duct stones, pancreatitis, or pancreatic cancer, insufficiency Drugs eBooks. Life Sciences Links. Life Sciences Home News Lab Instruments

These Victoza pancreatic cancer findings prompted the 2024 FDA Victoza pancreatic cancer warning, three years after the drug was first approved in the United States. Alarmingly, while the Victoza warning label was updated to include new warning information, the term pancreatic cancer was not added to the Victoza drug label.

New treatments, especially for late-stage pancreatic cancer, are urgently needed. A team of researchers led by Anita S. Chong, PhD, Professor of Surgery at the University of Chicago, in collaboration with Cinkate Pharmaceutical Corp, recently tested a new cancer drug, called CK21, on patient-derived pancreatic tumor organoids and pancreatic

A new drug candidate permanently modifies a wily cancer-causing mutation, paving the way for making pancreatic cancer treatable, or perhaps even curable.

The incidence of pancreatic cancer is rising, and some reports project that the number of new pancreatic cancer cases and pancreatic cancer deaths will more than double by 2024. Pancreatic ductal adenocarcinoma (PDA) accounts for more than 90% of pancreatic cancer cases.

Old chemotherapy drug, new pancreatic cancer therapy? . Faster detection of pancreatic cancer . Drug developed for